</>Build with Tariff Intelligence|Programmatic access to tariff calculations and HS code classification.Explore Developer Resources →
3002.13.00.10/Atezolizumab Monoclonal Antibody/Japan

Atezolizumab Monoclonal Antibody from Japan

Atezolizumab humanized IgG1 blocking PD-L1 for bladder cancer. Bulk unmixed HTS 3002.13.0010.

Duty Rate — Japan → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• PD-L1 specificity docs

• Trial kit exclusions